2-Chloro-1-(1-(3-fluorophenyl)-2,5-dimethyl-1H-pyrrol-3-yl)ethanone, 95.0%, 500mg

N,N'-Dibutylquinacridone>98.0%(HPLC)(N)1g

Ammonio cerio(IV) solfato diidrato, minimo 99%, pa, 50 g, confezione in plastica.

1-(Diphenylmethyl)azetidine-3-carboxylic acid, 95.0%, 25g

N-[3-Fluoro-4-[[1-methyl-6-(1H-pyrazol-4-yl)-1H-indazol-5-yl]oxy]phenyl]-1-(4-fluorophenyl)-1,2-dihydro-6-methyl-2-oxo-3-pyridinecarboxamide, 98%, 10mg

Ethyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-imidazole-5-carboxylate, 97%, 250mg

trans-4-(4-Chlorophenyl)cyclohexanecarboxylic acid, 98%, 500g

2-Bromo-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine, 97%, 1g

Ethyl 2-Aminothiazole-5-acetate, 95.0%, 250mg

Nitrato di platino(II) 5 g

1-Acetylpiperidine-4-carboxylic acid, 98.0%, 5g

(5-Bromo-1-methyl-1H-pyrazol-4-yl)methanol, 95.0%, 5g

(3,4-DIHYDROXYPHENYL)(P-TOLYL)METHANONE, 95.0%, 100mg